KOD: Gunggung dhuwit awis saben saham Kodiak Sciences Inc.

Lambang korporat lan logo Kodiak Corp (KOD)

Despite the binary development risks and the management's history of past failures, the team of top-tier ophthalmologists at Kodiak Sciences Inc. (KOD) relies on a powerful scientific foundation. The cash per share clearly demonstrates financial stability, while the 1.35 level captures the current state of liquidity. The business is currently executing a strategic pivot, focusing on cost optimization and the search for new global partners in the field of retinal treatment.

Dhuwit awis saben saham Kodiak Pharma (KOD): kanggo periode 04.07.2022 - 21.11.2026

Rincian metrik komprehensif lan analitis Kodiak Corp (KOD)

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:Kodiak Pharma KOD
Produk asil prodhuksi Kodiak Pharma

This indicator determines the volume of liquid assets per common share, allowing for an assessment of the company's intrinsic value and the risk of capital deficiency. The trend in average cash per share is critical for Kodiak Sciences Inc. (KOD), as in the absence of revenue, this reserve serves as the sole funding source for costly clinical trials of ophthalmological drugs.